Supremex's 34% EBITDA Jump Says One Thing: The Market Still Prices It Like a Dead Cat

Q2 improved the right lines: EBITDA, mix, and cash flow

Supremex's second quarter looked stronger than the stock's reaction suggested.

Just after the close, the company delivered 33.8% EBITDA growth on CAD 71.6 million of revenue, up 8.5%. EBITDA reached CAD 7.8 million at 10.9% margin versus 8.8% a year earlier, and free cash flow turned positive despite a deliberate inventory build tied to tariff planning. Taken together, that points to an operating improvement rather than a top-line outlier.

The profitability rebound was real, if still early. Reported net income flipped to CAD 1.0 million from a year-ago CAD 0.3 million loss. One quarter is not enough to settle the turnaround debate, but it does narrow it.

The market reaction was muted. The shares were last seen at $3.68, down 0.54%. That does not prove the stock is mispriced, but it does suggest investors still want more confirmation before treating this as a sustained rerating story.

Packaging mix is changing the business composition

The headline was EBITDA, but the more durable change was under the hood.

Packaging growth came with better mix

The quarter was not just about selling more. The product mix kept improving. Packaging revenue reached CAD 26.4 million, up 19%, while core packaging growth was 27.6% excluding commercial print. That matters because packaging is becoming a larger part of the revenue base, supported by folding carton, e-commerce secondary packaging, and acquisition contribution.

Packaging and specialty products now represent 37% of consolidated revenue, up from about one-third a year earlier. Management also said the packaging transition is now showing up in results, not just in strategy presentations. That makes this less of a narrative about future diversification and more of an operating shift already visible in the numbers.

Goldrich and envelope optimization are starting to show up

Synergy talk is only useful if it reaches the financial statements. In Q2, there were early signs that this is happening.

Goldrich added an approximately CAD 30 million-revenue folding-carton platform, and management said purchasing and manufacturing synergies are already underway. At the same time, envelope-side optimization has delivered roughly one-quarter of the expected CAD 1.4 million annual benefit in the second quarter.

That does not prove long-term margin targets will be met. It does show that Supremex is not only gaining better mix; it is also starting to improve operating leverage from acquisitions and cost initiatives.

What the market has to price from here

The next question is less about whether Supremex can post one good quarter. It is whether investors will start valuing the business for:

• a growing packaging mix instead of a mostly envelope-led story
• margin support from both mix and cost initiatives
• cash generation that remained positive despite tariff-related inventory planning

Those are the signals that would matter most for a rerating.

Bull case and bear case: one quarter improved the story, but it did not close the debate

This is no longer just a strategy story. Execution is now showing up in revenue mix, EBITDA, and free cash flow. What remains unsettled is whether this is the start of a rerating or simply a stronger quarter inside an still-underfollowed small-cap.

Bull case: the operating turn is becoming harder to ignore

If management can keep converting packaging-led growth into profit and cash, the stock may have room to catch up. The post-earnings reaction was flat, and the shares were last seen at $3.68, down 0.54%, which leaves room for sentiment to improve if results stay constructive.

More important, the packaging transition is no longer only a slide-deck story. Management said it is now visible in results, and Goldrich is already contributing to early synergy capture. That alignment between strategy and execution is usually where more serious interest begins.

Bear case: one quarter does not prove durability

The cautious view is also reasonable. A single quarter does not settle a turnaround, and the flat stock reaction suggests investors still expect some doubt to persist.

The clearest overhang is trade policy. Management said tariffs remain a material risk, and Supremex is responding by staging inventory in the U.S., using American facility capacity, and temporarily limiting some cross-border shipments. If those steps only delay pressure rather than neutralize it, the market may remain hesitant.

What would decide the next move

The next two quarters should make the direction clearer:

• whether packaging growth continues to lift consolidated margins
• whether synergy capture accelerates beyond the early stages reported in Q2
• whether free cash flow stays positive as inventory and operational changes settle
• whether the market finally rewards the operating improvement with a firmer valuation response